CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 256 filers reported holding CRISPR THERAPEUTICS AG in Q4 2019. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $796,649 | -18.2% | 14,750 | +3.2% | 0.00% | 0.0% |
| Q1 2024 | $974,281 | +12.7% | 14,294 | +3.5% | 0.00% | -50.0% |
| Q4 2023 | $864,507 | +27.4% | 13,810 | -7.6% | 0.00% | +100.0% |
| Q3 2023 | $678,583 | +30.7% | 14,950 | +61.7% | 0.00% | 0.0% |
| Q2 2023 | $519,171 | +22.2% | 9,248 | -1.6% | 0.00% | 0.0% |
| Q1 2023 | $424,938 | -11.4% | 9,395 | -20.3% | 0.00% | 0.0% |
| Q4 2022 | $479,458 | -38.8% | 11,795 | -1.5% | 0.00% | 0.0% |
| Q3 2022 | $783,000 | +15.1% | 11,977 | +7.1% | 0.00% | 0.0% |
| Q2 2022 | $680,000 | +5.4% | 11,185 | +8.8% | 0.00% | 0.0% |
| Q1 2022 | $645,000 | -13.1% | 10,281 | +5.0% | 0.00% | 0.0% |
| Q4 2021 | $742,000 | -45.5% | 9,790 | -19.6% | 0.00% | -50.0% |
| Q3 2021 | $1,362,000 | -10.7% | 12,170 | +29.1% | 0.00% | -33.3% |
| Q2 2021 | $1,526,000 | -6.2% | 9,428 | -29.4% | 0.00% | 0.0% |
| Q1 2021 | $1,627,000 | -10.3% | 13,352 | +12.7% | 0.00% | -25.0% |
| Q4 2020 | $1,814,000 | +107.3% | 11,850 | +13.3% | 0.00% | +100.0% |
| Q3 2020 | $875,000 | +182.3% | 10,459 | +147.9% | 0.00% | +100.0% |
| Q2 2020 | $310,000 | -41.7% | 4,219 | -66.3% | 0.00% | -50.0% |
| Q1 2020 | $532,000 | -44.0% | 12,536 | -19.7% | 0.00% | -33.3% |
| Q4 2019 | $950,000 | +61.3% | 15,604 | +8.5% | 0.00% | +50.0% |
| Q3 2019 | $589,000 | -16.2% | 14,376 | -3.7% | 0.00% | 0.0% |
| Q2 2019 | $703,000 | +27.1% | 14,935 | -3.6% | 0.00% | 0.0% |
| Q1 2019 | $553,000 | +30.7% | 15,486 | +4.7% | 0.00% | 0.0% |
| Q4 2018 | $423,000 | -39.2% | 14,791 | -12.8% | 0.00% | 0.0% |
| Q3 2018 | $696,000 | +186.4% | 16,964 | +63.6% | 0.00% | +100.0% |
| Q4 2017 | $243,000 | – | 10,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
| Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
| EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
| NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
| ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
| NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
| Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
| Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |